Abstract Purpose Male Breast Cancer (MBC) remains a poor understood disease.
Prognostic factors are not well established and specific prognostic subgroups are warranted …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Background Male breast cancer (MBC) is rare. Molecular subtype has been utilized widely
in female breast cancer. But the relationship between subtype and prognosis in MBC …

Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …

Objective Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and
in the male population. Data is usually extrapolated from female breast cancer (FBC) …

Male breast cancer (BC) represents less than 1% of male tumors. Little is known about male
BC characteristics, management, and survival, with many studies based on a small number …

Background Male breast cancer (MBC) is a rare disease accounting for approximately 1% of
all breast carcinomas. Presently treatment recommendations are derived from the standards …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

Aim: The aim of this study was to assess the molecular subtype profiles of male breast
cancer (MBC) and subsequent clinical outcome using a validated 6-marker …

Backgrounds Male breast cancer (MBC) is a rare disease and accounts for< 1% of all breast
cancers. Methods We retrospectively analyzed clinicopathologic characteristics and …